An ELISA Microarray Platform for Validating Cancer Biomarkers.
Journal Article
·
· BIOforum Europe, 10:14-15
OSTI ID:948416
The number of known circulating proteins that have potential for detecting cancer is rapidly growing. It seems clear, though, that variability in biomarker levels in both healthy and diseased populations will prevent most of these proteins from being useful. It also appears that a unique profile of biomarkers will be needed to accurately detect each type of cancer and that it will be necessary to evaluate blood samples from thousands of people to validate that profile. We are developing an antibody microarray platform that can be used to efficiently accomplish this task.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (US)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 948416
- Report Number(s):
- PNNL-SA-50987; 400412000
- Journal Information:
- BIOforum Europe, 10:14-15, Journal Name: BIOforum Europe, 10:14-15 Vol. 10
- Country of Publication:
- United States
- Language:
- English
Similar Records
ELISA microarray technology as a high-throughput system for cancer biomarker validation
A rational approach for discovering and validating cancer markers in very small samples using mass spectrometry and ELISA microarrays
A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays
Journal Article
·
Sat Dec 31 23:00:00 EST 2005
· Expert Review of Proteomics
·
OSTI ID:877580
A rational approach for discovering and validating cancer markers in very small samples using mass spectrometry and ELISA microarrays
Journal Article
·
Fri Oct 01 00:00:00 EDT 2004
· Disease Markers
·
OSTI ID:15010737
A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays
Journal Article
·
Wed Dec 31 23:00:00 EST 2003
· Disease Markers
·
OSTI ID:1197934